SRH works within the biomedical pharmaceutical sector to innovate new products to improve quality of life. This is conducted through research and integration of pharmaceutical delivery mechanisms with active pharmaceutical compounds. Newly formulated products are re-purposed for consumer markets. We work from benchtop through Go-To-Market milestones and territory expansion.
Pharmaceutical Development
Alternate Site Care
Alternate site services are those healthcare services provided outside of the hospital. SRH has developed, built, managed and provided innovation in these sectors such as diagnostic radiology, outpatient surgery, therapeutic radiology, medical equipment, rehabilitation, assisted living, biotechnology, healthcare IT platforms and consumer healthcare.
Eldercare
Asia retirees and the aging population are expected to grow dramatically in the near term. As a majority of this population will have at least one Non-Communicable Disease (NCD), supported living facilities are expected to increase in demand. Traditionally, future eldercare may become more complex than current resources within one’s household. However, the elder population may otherwise be capable of independent living through assisted support services. SRH provides turnkey services in planning, development, construction, marketing,facility management and ongoing healthcare services.
Radiology
SRH has experience in joint ventures, Public Private Partnerships and partners with healthcare systems. These structures often help provide off balance sheet financing as well as ability to move quickly in the market for patient access, market expansion and feeder systems.Whether the market entry is initially through an acquisition, or greenfield development; SRH can provide turnkey solutions including facility design, equipment selection and installation supervision and staffing and facility opening services.SRH also provides management services for professional results as well as regulatory advice, billing and collections and defined management projects such as capitated pricing and Accountable Care Organization planning.
Home Infusion
Home infusion therapy is an alternate site healthcare delivery segment which allows patients to continue their care, at home or work, rather than be hospitalized when receiving intravenous care. The result is more efficient services, lower costs and greater patient control. While home infusion is a 25 year standard of care in Europe and North America, Asia can capitalize on this model as independent companies or hospital partnerships.
Medical Support Services
As improvements in medical care leads to increased life expectancy, there will be an increase in population with a NCD’s such as diabetes, heart disease, orthopedic issues, cancer and pulmonary problems. More than half of the population over 50 years old has at least one NCD. Often times, these individuals become travel restricted as medical support services are either lacking or need coordination. Having travel medical support services available may not only improve quality of life but, also better access to care. SRH works in this arena to develop coordinated care.
Novel Pharmaceutical Treatment Programs
For more than 500 million years, humans have developed natural receptors for cannabinoids (CBD’s) with compounds called endocannabinoids. Certain governments have recently approved exogenous use of CBD’s for disease states such as epilepsy, gastroenterology, dermatology and pain management. However, in most circumstances, current treatment regimens use a common treatment plan irrespective of the ailment or acuity. SRH is engaged in the evaluation of CBD’s for these disease states through research, treatment planning and outcomes in conjunction with regulatory bodies, physicians and the patient community.